Innovation1 Biotech Inc (IVBT) Predicción del precio de las acciones

Innovation1 Biotech, Inc. is a clinical-stage drug discovery company, which focuses on developing modified Schedule 1 molecules of botanical origin for therapeutic use. The company is headquartered in Rockaway, New Jersey and currently employs 0 full-time employees. The company went IPO on 2017-02-06. The firm has no operations and is evaluating a number of strategic alternatives including, but not limited to, seeking to acquire a new business in the United States, including potentially by means of a reverse merger with an operating entity. The firm has no sources of revenue.